M. Bro¨ring et al. / Inorganica Chimica Acta 358 (2005) 3122–3134
3127
3
1
(CD2Cl2): d 1.09 (t, 6H, JHH = 7.6 Hz, 2 · CH2CH3),
124.1, 125.0 (q, JCF = 272.6 Hz, 8 · CF3), 126.8, 129.1
3
2
1.19 (t, 6H, JHH = 7.6 Hz, 2 · CH2CH3), 2.42 (q, 4H,
(q, JCF = 31.5 Hz, 8 · meta-C), 135.2 (br s, 8 · ortho-
C), 138.5, 139.3, 141.0, 151.5, 161.9 (q, JBC = 49.6 Hz,
3JHH = 7.6 Hz, 2 · CH2CH3), 2.50 (s, 6H, 2 · terminal
1
3
CH3), 2.58 (q, 4H, JHH = 7.6 Hz, 2 · CH2CH3), 3.48
4 · ipso-C), 171.6. 19F NMR (CD2Cl2): d ꢀ62.7. 31P
(br s, 3H, CNCH3), 6.75, 6.92 (2 · s, 4H, 2 · meso-H
+ 2 · b-H), 7.57 (s, 4H, 4 · para-H), 7.72 (s, 8H,
8 · ortho-H). 13C NMR (CD2Cl2): d 14.6, 16.5, 18.4,
NMR (CD2Cl2):
d
ꢀ22.5. MS (FAB): m/z 542
[M ꢀ BArF]+, 466 [M ꢀ BArF ꢀ PMe3]+.
Preparation of bis(trimethylphosphino)-(3,4,13,14-
tetraethyl-2,15-dimethyltripyrrinato)palladium(II) tetra-
kis-[3,5-bis(trifluoromethyl)phenyl]borate (18). The
title compound was prepared from TrpyPdIIOAcF (5)
(52.4 mg, 90.3 lmol), NaBArF (79.9 mg, 90.3 lmol)
and trimethylphosphine (18.3 ll, 180.6 lmol) according
to the general procedure and yielded a violet solid.
Spectroscopic data for 18. (121.0 mg, 91%), m.p.
138 ꢁC (decomp.) (C62H60BF24N3P2Pd requires: C,
50.24; H, 4.08; N, 2.84. Found: C, 49.87; H, 4.07; N,
2.96%). 1H NMR (CD2Cl2): d 0.79 (t, 18H, N =
7.6 Hz, 6 · PCH3), 1.08 (t, 6H 3JHH = 7.6 Hz,
18.5, 20.7, 117.8 (m, 4 · para-C), 124.0, 124.9 (q,
1JCF = 271.6 Hz, 8 · CF3), 125.7, 129.1 (q, JCF
=
2
31.5 Hz, 8 · meta-C), 135.2 (s, 8 · ortho-C), 138.4,
1
139.5, 139.7, 151.7, 162.1 (q, JBC = 49.9 Hz, 4 · ipso-
C), 174.3. The signals for the isonitrile ligand were not
detected. 19F NMR (CD2Cl2): d ꢀ62.7.
Preparation of tert-butylamino-(3,4,13,14-tetraethyl-
2,15-dimethyltripyrrinato)-palladium(II) tetrakis-[3,5-
bis(trifluoromethyl)phenyl]borate (15). The title
compound was prepared from TrpyPdIIOAcF (5)
(37.3 mg, 64.3 lmol), NaBArF (57.0 mg, 64.3 lmol)
and tert-butylamine (6.75 ll, 64.3 lmol) according to
the general procedure and yielded a violet solid.
Spectroscopic data for 15. (67.7 mg, 75%), m.p. 84 ꢁC
(decomp.) (C60H53BF24N4Pd requires: C, 51.35; H, 3.81;
3
2 · CH2CH3), 1.16 (t, 6H JHH = 7.6 Hz, 2 · CH2CH3),
3
2.43 (q, 4H, JHH = 7.6 Hz, 2 · CH2CH3), 2.64 (q, 4H,
3JHH = 7.6 Hz, 2 · CH2CH3), 2.81 (s, 6H, 2 · terminal
CH3), 7.04, 7.13 (2 · s, 4H, 2 · meso-H + 2 · b-H),
7.56 (s, 4H, 4 · para-H), 7.72 (s, 8H, 8 · ortho-H). 13C
NMR (CD2Cl2): d 13.6 [t, N = 26.7 Hz, 2 · P(CH3)3],
15.0, 17.5, 18.6, 18.8, 20.3, 117.8 (m, 4 · para-C), 125.0
1
N, 3.99. Found: C, 51.37; H, 3.66; N, 3.66%). H NMR
3
(CD2Cl2): d 1.09 (t, 6H, JHH = 7.6 Hz, 2 · CH2CH3),
3
1.16 (t, 6H, JHH = 7.6 Hz, 2 · CH2CH3), 1.28 [s, 9H,
3
1
C(CH3)3], 2.40 (q, 4H, JHH = 7.6 Hz, 2 · CH2CH3),
(q, JCF = 272.2 Hz, 8 · CF3), 126.3, 126.8, 129.2 (q,
3
2.57 (q, 4H, JHH = 7.6 Hz, 2 · CH2CH3), 2.66 (s, 6H,
2JCF = 31.5 Hz, 8 · meta-C), 135.2 (br s, 8 · ortho-C),
136.2, 139.4, 145.3, 153.2, 161.9 (q, JBC = 49.6 Hz,
1
2 · terminal CH3), 6.85, 6.91 (2 · s, 4H, 2 · meso-
H + 2 · b-H), 7.52 (s, 4H, 4 · para-H), 7.74 (s, 8H,
8 · ortho-H). The signal of the amine hydrogens was
not detected. 13C NMR (CD2Cl2): d 14.2, 14.5, 16.6,
18.3, 18.7, 30.9, 117.9 [s(br), 4 · para-C], 123.6, 125.0
4 · ipso-C), 169.7. 19F NMR (CD2Cl2): d ꢀ62.7. 31P
NMR (CD2Cl2):
d
ꢀ18.4. MS (FAB): m/z 618
[M ꢀ BArF]+, 542 [M ꢀ BArF ꢀ PMe3]+, 466 [M ꢀ
BArF ꢀ 2 PMe3]+.
1
2
(q, JCF = 272.7 Hz, 8 · CF3), 126.9, 129.3 (qq, JCF
=
Preparation of triethylphosphano-(3,4,8,9,13,14-hexa-
ethyl-2,15-dimethyltripyrrinato)-palladium(II) tetrakis-
[3,5-bis(trifluoromethyl)phenyl]borate (19). The title
compound was prepared from TrpyPdIIOAcF (1)
(62.2 mg, 97.8 lmol), NaBArF (86.7 mg, 97.8 lmol)
and excess triethylphosphane according to the general
procedure and yielded a violet solid.
3
31.5 Hz, JBC = 2.9 Hz, 8 · meta-C), 135.2 (br s,
8 · ortho-C), 139.3, 139.7, 140.5, 151.0, 162.2 (q,
1JBC = 49.9 Hz, 4 · ipso-C), 170.7. 19F NMR (CD2Cl2):
d ꢀ62.7.
Preparation of trimethylphosphino-(3,4,13,14-tetra-
ethyl-2,15-dimethyltripyrrinato)-palladium(II) tetrakis-
[3,5-bis(trifluoromethyl)phenyl]borate (17). The title
compound was prepared from TrpyPdIIOAcF (5)
(46.5 mg, 80.2 lmol), NaBArF (71.0 mg, 80.2 lmol)
and trimethylphosphine (8.10 ll, 80.2 lmol) according
to the general procedure and yielded a violet solid.
Spectroscopic data for 17. (106.0 mg, 94%), m.p.
158 ꢁC (C59H51BF24N3PPd requires: C, 50.39; H, 3.66;
Spectroscopic data for 19. (125.0 mg, 85%), m.p.
119 ꢁC (decomp.) (C66H65BF24N3PPd requires: C,
52.69; H, 4.36; N, 2.79. Found: C, 52.77; H, 4.51; N,
1
3
2.66%). H NMR (CD2Cl2): d 0.77 [t(br), 9H, JHH
=
3
7.6 Hz, 3 · PCH2CH3], 1.07 (t, 6H, JHH = 7.6 Hz,
2 · CH2CH3), 1.16 (t, 6H, 3JHH = 7.6 Hz, 2 · CH2CH3),
3
1.19 (t, 6H, JHH = 7.6 Hz, 2 · CH2CH3), 1.61 (m, 6H,
N, 2.99. Found: C, 50.82; H, 3.87; N, 2.88%). 1H
3 · PCH2CH3), 2.42 (q, 4H, JHH = 7.6 Hz, 2 · CH2-
3
3
1.09 (t, 6H, JHH = 7.6 Hz,
3
NMR (CD2Cl2):
d
CH3), 2.66 (q, 4H, JHH = 7.6 Hz, 2 · CH2CH3), 2.69
2 · CH2CH3), 1.17 (t, 6H, 3JHH = 7.6 Hz, 2 · CH2CH3),
(q, 4H, JHH = 7.6 Hz, 2 · CH2CH3), 2.81 (s, 6H,
3
3
1.33 (d, 9H, JHP = 11.4 Hz, 3 · PCH3), 2.43 (q, 4H,
2 · terminal CH3), 7.05 (s, 2H, 2 · meso-H), 7.56 (s,
4H, 4 · para-H), 7.72 (s, 8H, 8 · ortho-H). 13C NMR
(CD2Cl2): d 7.0 (br s, 3 · PCH2CH3), 15.0 (br s,
2 · CH2C H3 + 3 · PC H2CH3), 17.6, 17.7, 18.1, 18.7,
18.9, 21.4, 117.9 (m, 4 · para-C), 123.1, 125.0 (q,
3JHH = 7.6 Hz, 2 · CH2CH3), 2.58 (br s, 4H,
2 · CH2CH3), 2.70 (s, 6H, 2 · terminal CH3), 6.90,
6.97 (2 · s, 4H, 2 · meso-H + 2 · b-H), 7.58 (s, 4H,
4 · para-H), 7.74 (s, 8H, 8 · ortho-H). 13C NMR
1
14.7, 16.7, 17.8 (d, JCP = 28.6 Hz,
2
(CD2Cl2):
d
1JCF = 272.6 Hz, 8 · CF3), 129.3 (q, JCF = 31.6 Hz,
3 · PCH3), 18.4, 18.5, 20.9, 117.9 (m, 4 · para-C),
8 · meta-C), 135.2 (br s, 8 · ortho-C), 135.9, 139.5,